When was apotex's ruxolitinib approved?

When did Apotex get ruxolitinib approval?

Apotex’s ruxolitinib (a JAK inhibitor) was approved in the United States on September 16, 2014. [1]

What was Apotex’s ruxolitinib approval for?

This approval corresponds to Apotex’s generic ruxolitinib product, approved as a ruxolitinib tablet under the U.S. FDA pathway reflected in the approval record. [1]

Source

[1] https://www.drugpatentwatch.com/p/apotex-ruxolitinib/